A role for IRF3-dependent RXRα repression in hepatotoxicity associated with viral infections

Viral infections and antiviral responses have been linked to several metabolic diseases, including Reye's syndrome, which is aspirin-induced hepatotoxicity in the context of a viral infection. We identify an interferon regulatory factor 3 (IRF3)–dependent but type I interferon–independent pathway that strongly inhibits the expression of retinoid X receptor α (RXRα) and suppresses the induction of its downstream target genes, including those involved in hepatic detoxification. Activation of IRF3 by viral infection in vivo greatly enhances bile acid– and aspirin-induced hepatotoxicity. Our results provide a critical link between the innate immune response and host metabolism, identifying IRF3-mediated down-regulation of RXRα as a molecular mechanism for pathogen-associated metabolic diseases.

[1]  M. Krečmerová,et al.  Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.

[2]  K. Takeda,et al.  Acetylsalicylate (ASA)-induced mitochondrial dysfunction and its potentiation by Ca2+. , 2008, Liver.

[3]  J. Potter,et al.  GLUCURONIDATION OF THE ASPIRIN METABOLITE SALICYLIC ACID BY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES AND HUMAN LIVER MICROSOMES , 2006, Drug Metabolism and Disposition.

[4]  P. Giral,et al.  Review article: an unexpected virus–host interaction – the hepatitis C virus‐diabetes link , 2005, Alimentary pharmacology & therapeutics.

[5]  A. Hoffmann,et al.  Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors , 2005, Cell.

[6]  F. Anania,et al.  Epstein-Barr virus induced hepatitis: An important cause of cholestasis. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  S. Lemon,et al.  Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes* , 2005, Journal of Biological Chemistry.

[8]  P. Patterson,et al.  Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus , 2005, International Journal of Developmental Neuroscience.

[9]  C. Carlberg,et al.  Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. , 2005, Journal of molecular biology.

[10]  H. Sugino,et al.  Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection. , 2004, The Journal of pediatrics.

[11]  G. Haegeman,et al.  Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression , 2004 .

[12]  P. Rogan,et al.  Development and Refinement of Pregnane X Receptor (PXR) DNA Binding Site Model Using Information Theory , 2004, Journal of Biological Chemistry.

[13]  M. Dawson,et al.  These include: , 1993 .

[14]  David Baltimore,et al.  One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.

[15]  Y. Hiasa,et al.  Gianotti-Crosti syndrome caused by acute hepatitis B virus genotype D infection. , 2004, Internal medicine.

[16]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[17]  G. Cheng,et al.  Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection , 2004, The Journal of experimental medicine.

[18]  P. Rao,et al.  Dual Roles for the Notch Target Gene Hes-1 in the Differentiation of 3T3-L1 Preadipocytes , 2004, Molecular and Cellular Biology.

[19]  Tak W. Mak,et al.  Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β , 2004 .

[20]  Shelly C. Lu,et al.  Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. , 2004, Molecular pharmacology.

[21]  J. Gustafsson,et al.  Glucocorticoid response and promoter occupancy of the mouse LXRα gene , 2003 .

[22]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[23]  G. Cheng,et al.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. , 2003, Molecular cell.

[24]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[25]  L. Påhlman,et al.  Variable expression of CYP and Pgp genes in the human small intestine , 2003, European journal of clinical investigation.

[26]  P. Tebas,et al.  Emerging bone problems in patients infected with human immunodeficiency virus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Feingold,et al.  Repression of Farnesoid X Receptor during the Acute Phase Response* , 2003, The Journal of Biological Chemistry.

[28]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[29]  P. Chambon,et al.  Phosphorylation by p38MAPK and recruitment of SUG‐1 are required for RA‐induced RARγ degradation and transactivation , 2002, The EMBO journal.

[30]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[31]  K. Feingold,et al.  Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. , 2002, Biochemical and biophysical research communications.

[32]  S. Stifani,et al.  Role for Hes1-Induced Phosphorylation in Groucho-Mediated Transcriptional Repression , 2002, Molecular and Cellular Biology.

[33]  T. Langmann,et al.  The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux* , 2001, The Journal of Biological Chemistry.

[34]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Evans,et al.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Chambon,et al.  Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Joven,et al.  The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. , 2000, Life sciences.

[38]  P. Chambon,et al.  Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis , 2000, Nature.

[39]  P. Vallance,et al.  Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. , 2000, Circulation.

[40]  Mark A. Magnuson,et al.  Hepatocyte-Specific Mutation Establishes Retinoid X Receptor α as a Heterodimeric Integrator of Multiple Physiological Processes in the Liver , 2000, Molecular and Cellular Biology.

[41]  K. Feingold,et al.  The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver* , 2000, The Journal of Biological Chemistry.

[42]  P. Edwards,et al.  Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor* , 2000, The Journal of Biological Chemistry.

[43]  A. Aggarwal,et al.  Investigation of an epidemic of Reye's syndrome in northern region of India. , 1999, Indian pediatrics.

[44]  J. Pascussi,et al.  Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. , 1999, Biochemical and biophysical research communications.

[45]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[46]  R. Holman,et al.  Reye's syndrome in the United States from 1981 through 1997. , 1999, The New England journal of medicine.

[47]  K. Wikvall,et al.  6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes , 1999 .

[48]  F. Berthou,et al.  Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[49]  T. Sueyoshi,et al.  The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.

[50]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[51]  J. Lemasters,et al.  Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. , 1997, Toxicology and applied pharmacology.

[52]  M. Ciotti,et al.  Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. , 1997, Pharmacogenetics.

[53]  A. Mason,et al.  Co-existence of hepatitis A and adult Reye's syndrome. , 1997, Gut.

[54]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[55]  K. Umesono,et al.  LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.

[56]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[57]  J. Vonesch,et al.  Genetic analysis of RXRα developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis , 1994, Cell.

[58]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[59]  R. Evans,et al.  RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. , 1994, Genes & development.

[60]  B. Woodfin,et al.  The influenza B virus mouse model of Reye's syndrome: pathogenesis of the hypoglycaemia. , 1993, International journal of experimental pathology.

[61]  C. Carlberg,et al.  Two nuclear signalling pathways for vitamin D , 1993, Nature.

[62]  J. Gustafsson,et al.  Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Koeffler,et al.  9-cis-retinoic acid : effects on normal and leukemic hematopoiesis in vitro , 1993 .

[64]  S. Treon,et al.  Monoclonal antibody therapy in the treatment of Reye's syndrome. , 1992, Medical hypotheses.

[65]  Philippe Kastner,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.

[66]  J. Orlowski,et al.  Reye's syndrome: a case control study of medication use and associated viruses in Australia. , 1990, Cleveland Clinic journal of medicine.

[67]  J. Caldwell,et al.  Effect of interferon synthesis upon the metabolism of [carboxyl-14C]-aspirin in the mouse. , 1987, Biochemical pharmacology.

[68]  C. Lee,et al.  Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate. , 1986, Archives of biochemistry and biophysics.

[69]  R. Mitchell,et al.  Prognosis and diagnosis of Reye syndrome by discriminant analysis. , 1985, Experimental and molecular pathology.

[70]  F. Ruben,et al.  Epidemiologic studies of Reye's syndrome: cases seen in Pittsburgh, October 1973-April 1975. , 1976, American journal of public health.

[71]  F. Iwańczak,et al.  [2 cases of Stevens-Johnson syndrome in children]. , 1973, Wiadomosci lekarskie.

[72]  W. Schubert,et al.  Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). , 1971, The New England journal of medicine.

[73]  R. Reye,et al.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA , 1963 .

[74]  R. Reye,et al.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD. , 1963, Lancet.

[75]  G. Haegeman,et al.  Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Hoffmann,et al.  One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. , 2004, Cell.

[77]  M. Dawson,et al.  Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. , 2004, Molecular and cellular biology.

[78]  T. Mak,et al.  Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Gustafsson,et al.  Glucocorticoid response and promoter occupancy of the mouse LXRalpha gene. , 2003, Biochemical and biophysical research communications.

[80]  K. Wikvall,et al.  6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. , 1999, Biochimica et biophysica acta.

[81]  W. Reinus,et al.  Hepatitis C-associated osteosclerosis: late onset after blood transfusion in an elderly woman. , 1998, The Journal of clinical endocrinology and metabolism.

[82]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. , 1994, Cell.

[83]  I. Issemann,et al.  The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. , 1993, Biochimie.

[84]  H. Koeffler,et al.  9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. , 1993, Blood.